Model for end-stage liver disease (MELD) score and cost-effectiveness on living donor liver transplantation

被引:1
|
作者
Ichida, Takafumi [1 ]
Narita, Yutaka [1 ]
Murakami, Romi [1 ]
机构
[1] Juntendo Univ, Sch Med, Shizuoka Hosp, Dept Gastroenterol & Hepatol, Izunokuni 4102295, Japan
关键词
D O I
10.1007/s00535-006-1959-y
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1023 / 1024
页数:2
相关论文
共 50 条
  • [21] The model for end-stage liver disease score is useful for predicting economic outcomes in adult cases of living donor liver transplantation
    Takayuki Kogure
    Yoshiyuki Ueno
    Naoki Kawagishi
    Noriatsu Kanno
    Yoko Yamagiwa
    Koji Fukushima
    Susumu Satomi
    Tooru Shimosegawa
    Journal of Gastroenterology, 2006, 41 : 1005 - 1010
  • [22] The model for end-stage liver disease score is useful for predicting economic outcomes in adult cases of living donor liver transplantation
    Kogure, Takayuki
    Ueno, Yoshiyuki
    Kawagishi, Naoki
    Kanno, Noriatsu
    Yamagiwa, Yoko
    Fukushima, Koji
    Satomi, Susumu
    Shimosegawa, Tooru
    JOURNAL OF GASTROENTEROLOGY, 2006, 41 (10) : 1005 - 1010
  • [23] Does Model for End-Stage Liver Disease Score Predict the Short-Term Outcome of Living Donor Liver Transplantation?
    Li, C.
    Wen, T.
    Yan, L.
    Li, B.
    Wang, W.
    Xu, M.
    Yang, J.
    Wei, Y.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (09) : 3620 - 3623
  • [24] Benefit of living donor liver transplantation in graft survival for extremely high model for end-stage liver disease score ≥35
    Yun, Sang Oh.
    Kim, Jongman
    Rhu, Jinsoo
    Choi, Gyu-Seong
    Joh, Jae-Won
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2023, 30 (12) : 1293 - 1303
  • [25] Value of the preoperative Model for End-stage Liver Disease score in predicting postoperative outcome in living donor liver transplantation recipients
    Y Nassar
    K Omar
    A Battah
    A Mwafy
    Critical Care, 17 (Suppl 2):
  • [26] Cost-effectiveness analysis of liver transplantation in biliary atresia according to the severity of end-stage liver disease
    Boonyanurak Sihaklang
    Songpon Getsuwan
    Oraluck Pattanaprateep
    Napapat Butsriphum
    Chatmanee Lertudomphonwanit
    Pornthep Tanpowpong
    Chollasak Thirapattaraphan
    Suporn Treepongkaruna
    BMC Pediatrics, 23 (1)
  • [27] Cost-effectiveness analysis of liver transplantation in biliary atresia according to the severity of end-stage liver disease
    Sihaklang, Boonyanurak
    Getsuwan, Songpon
    Pattanaprateep, Oraluck
    Butsriphum, Napapat
    Lertudomphonwanit, Chatmanee
    Tanpowpong, Pornthep
    Thirapattaraphan, Chollasak
    Treepongkaruna, Suporn
    BMC PEDIATRICS, 2023, 23 (01)
  • [28] Impact of model for end-stage liver disease (MELD) and delta MELD (MELD) on outcome following liver transplantation.
    Bhati, CS
    Tamijmarane, A
    Gunson, B
    Mayer, DF
    Buckels, JAC
    Mirza, DF
    Wigmore, SJ
    Brahmall, SR
    LIVER TRANSPLANTATION, 2006, 12 (05) : C80 - C80
  • [29] Calculation and comparison of the Model for End-Stage Liver Disease (MELD) score in patients accepted for liver transplantation in 1999 and 2004
    Floden, A.
    Castedal, M.
    Friman, S.
    Olausson, M.
    Backman, L.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (02) : 385 - 386
  • [30] Improvements in the model for end-stage liver disease (MELD) severity score.
    Dykstra, DM
    Wiesner, RH
    Port, FK
    Wolfe, RA
    Merion, RM
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 516 - 516